Company logo

ABCL - AbCellera Biologics Inc.

NASDAQ -> Healthcare -> Biotechnology
Vancouver, Canada
Type: Equity

ABCL price evolution
ABCL
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $158.32 $197.42 $204.75 $218.02
Short term investments $627.26 $613.42 $615.95 $603.48
Net receivables $30.59 $37.45 $45.68 $20
Inventory $1.11 $1.19 $1.45 $1.45
Total current assets $871.99 $919.52 $930.74 $940.65
Long term investments $65.94 $62.89 $58.79 $57.58
Property, plant & equipment $287.7 $277.21 $259.64 $233.19
Goodwill & intangible assets $168.23 $171.88 $174.55 $176.65
Total noncurrent assets $616.11 $592.67 $606.43 $557.27
Total investments $693.2 $676.3 $674.74 $661.06
Total assets $1488.09 $1512.19 $1537.17 $1497.92
Current liabilities
Accounts payable $104.97 $98.04 $116.14 $50.64
Deferred revenue $27.15 $33.89 $36.26 $37.22
Short long term debt
Total current liabilities $119.01 $110.24 $118.91 $89.59
Long term debt $71.22 $75.19 $78.08 $77.27
Total noncurrent liabilities $216.76 $219.18 $223.43 $199.83
Total debt $71.22 $75.19 $78.08 $77.27
Total liabilities $335.78 $329.42 $342.34 $289.42
Shareholders' equity
Retained earnings $279.79 $326.94 $355.55 $386.07
Other shareholder equity -$1.72 -$1.46 -$1.9 -$2.02
Total shareholder equity $1152.32 $1182.78 $1194.83 $1208.5
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $158.32 $411.54 $501.14 $594.12
Short term investments $627.26 $499.95 $246.84
Net receivables $30.59 $603.36 $160.58 $213.24
Inventory $1.11 $1.53 $1.67
Total current assets $871.99 $1025.49 $929.8 $813.33
Long term investments $65.94 $72.52 $50.31 $19.25
Property, plant & equipment $287.7 $217.25 $111.62 $17.92
Goodwill & intangible assets $168.23 $179.31 $196.2 $146.65
Total noncurrent assets $616.11 $515.42 $388.77 $192.21
Total investments $693.2 $572.47 $297.15 $19.25
Total assets $1488.09 $1540.91 $1318.57 $1005.54
Current liabilities
Accounts payable $104.97 $14.83 $90.41 $56.3
Deferred revenue $27.15 $41.13 $68.29 $32.48
Short long term debt $0.19
Total current liabilities $119.01 $118.32 $120.68 $103.49
Long term debt $71.22 $76.67 $36.41 $5.91
Total noncurrent liabilities $216.76 $189.31 $172.16 $71.54
Total debt $71.22 $76.67 $36.41 $6.1
Total liabilities $335.78 $307.63 $292.84 $175.03
Shareholders' equity
Retained earnings $279.79 $426.19 $267.67 $114.2
Other shareholder equity -$1.72 -$1.39 $0.28
Total shareholder equity $1152.32 $1233.28 $1025.73 $830.51
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue $9.18 $6.6 $10.06 $12.19
Cost of revenue
Gross Profit $9.18 $6.6 $10.06 $12.19
Operating activities
Research & development $48.62 $37.92 $36.47 $52.65
Selling, general & administrative $19.07 $17.84 $19.36 $18.91
Total operating expenses $75.23 $61.49 $61.45 $77.07
Operating income -$66.05 -$54.89 -$51.39 -$64.87
Income from continuing operations
EBIT -$48.6 -$39.28 -$38 -$48.15
Income tax expense -$1.45 -$10.67 -$7.48 -$8.04
Interest expense
Net income
Net income -$47.15 -$28.61 -$30.53 -$40.11
Income (for common shares) -$47.15 -$28.61 -$30.53 -$40.11
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $38.02 $485.42 $375.2 $233.16
Cost of revenue
Gross Profit $38.02 $485.42 $375.2 $233.16
Operating activities
Research & development $175.66 $107.88 $62.06 $29.39
Selling, general & administrative $75.18 $66.75 $48.76 $15.75
Total operating expenses $275.23 $268.91 $170.79 $77.12
Operating income -$237.21 $216.51 $204.41 $156.03
Income from continuing operations
EBIT -$174.03 $243.14 $224.37 $164.34
Income tax expense -$27.63 $80.58 $65.69 $38.91
Interest expense $4.04 $5.22 $6.51
Net income
Net income -$146.4 $158.52 $153.46 $118.92
Income (for common shares) -$146.4 $158.52 $153.46 $118.92
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income -$47.15 -$28.61 -$30.53 -$40.11
Operating activities
Depreciation $9.11 $7.41 $7.26 $7.12
Business acquisitions & disposals
Stock-based compensation $16.45 $15.86 $16.4 $15.47
Total cash flows from operations -$19.61 -$0.11 $19.9 -$44.06
Investing activities
Capital expenditures -$14.43 -$20.33 -$27.2 -$14.98
Investments -$20.18 $0.78 -$12.19 -$137.32
Total cash flows from investing -$24.32 -$12.79 -$34.39 -$149.61
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings $3.95 $7 $0.15 $0.49
Total cash flows from financing $3.77 $6.63 $0.42 -$0.46
Effect of exchange rate $1.07 -$1.06 $0.8 -$0.21
Change in cash and equivalents -$39.1 -$7.33 -$13.27 -$194.34
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income -$146.4 $158.52 $153.46 $118.92
Operating activities
Depreciation $30.89 $33.1 $17.25 $5.27
Business acquisitions & disposals -$11.46 -$85.86
Stock-based compensation $64.18 $49.48 $30.65 $8.4
Total cash flows from operations -$43.88 $277.36 $244.58 $22.69
Investing activities
Capital expenditures -$76.95 -$70.66 -$58.45 -$9.67
Investments -$168.91 -$296.4 -$294.96 -$19.25
Total cash flows from investing -$221.11 -$352.63 -$332.25 -$119.78
Financing activities
Dividends paid
Sale and purchase of stock $4.62 $523.84
Net borrowings $11.59 $2.43 -$0.95 $85.15
Total cash flows from financing $10.36 -$1.63 -$3.89 $683.65
Effect of exchange rate $0.59 -$9.6 -$1.43
Change in cash and equivalents -$254.04 -$86.49 -$92.97 $586.56
Fundamentals
Market cap $1.32B
Enterprise value $1.23B
Shares outstanding 290.82M
Revenue $38.03M
EBITDA -$143.14M
EBIT -$174.03M
Net Income -$146.40M
Revenue Q/Q -57.40%
Revenue Y/Y -92.17%
P/E ratio -9.00
EV/Sales 32.36
EV/EBITDA -8.60
EV/EBIT -7.07
P/S ratio 34.65
P/B ratio 1.14
Book/Share 3.97
Cash/Share 0.54
EPS -$0.50
ROA -9.70%
ROE -12.36%
Debt/Equity 0.29
Net debt/EBITDA -1.24
Current ratio 7.33
Quick ratio 7.32